Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
1,314,892
-
Share change
-
+63,817
-
Total reported value
-
$1,206,107
-
Price per share
-
$0.91
-
Number of holders
-
46
-
Value change
-
+$64,784
-
Number of buys
-
20
-
Number of sells
-
12
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q4 2024
As of 31 Dec 2024,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,314,892 shares.
The largest 10 holders included
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, SEEDS INVESTOR LLC, GOLDMAN SACHS GROUP INC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, NATIONAL BANK OF CANADA /FI/, Royal Bank of Canada, COMMONWEALTH EQUITY SERVICES, LLC, CIBC WORLD MARKET INC., and BANK OF MONTREAL /CAN/.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.